Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates (Q39823165)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

0 references

1 reference

based on heuristic

inferred from title

Arturo Reyes-Sandoval

object named as

Arturo Reyes-Sandoval

2

0 references

Stefania Capone

object named as

Stefania Capone

1

0 references

Adrian V. S. Hill

11

object named as

Adrian V S Hill

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Antonella Folgori

10

object named as

Antonella Folgori

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Mariarosaria Naddeo

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Loredana Siani

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Virginia Ammendola

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Christine S Rollier

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Alfredo Nicosia

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Stefano Colloca

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Riccardo Cortese

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

26 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

256-265

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Chimpanzee adenovirus vaccine protects against Zaire Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Chimpanzee-origin adenovirus vectors as vaccine carriers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Induction of mucosal immunity with a replication-defective adenoviral recombinant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Immunological techniques in viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

CD4+CD8+ murine intestinal intraepithelial lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Extrathymic CD4/CD8 double positive T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Prime-boost vectored malaria vaccines: progress and prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Adenovirus-mediated gene transfer to liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

A theoretical framework for the immunoepidemiology of Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Simian immunodeficiency virus infection of CD8+ lymphocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.10.041

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39823165&oldid=2195965136"